EMA revises the guideline for environmental risk assessment of medicinal products for human use

AdobeStock_749223704_compressed

The legislative requirement for the conduct of environmental risk assessments (ERAs) in the EU is not new, with the original guidance having been issued 18 years ago. However, 1 September 2024 marks the day when the revised guidance on the conduct of ERAs becomes effective, having been in the making since 2016 when the concept paper on the revision of the original ERA guidance was first released. This article discusses and analyses key changes of this revised guidance.

How to read this article 

Thank you for visiting Regulatory Rapporteur, you have now used up your content views.

To continue reading:

If you are a TOPRA member, or have already registered for limited free access, log in now (Option 1 below).

Not yet a member? You can either join TOPRA (Option 2 below), or register to view limited content for free (Option 3 below).

1. LOGIN

Already a TOPRA member?

Log-in now using your MyTOPRA credentials, for unlimited access to all Regulatory Rapporteur journal articles, the online archive and latest industry news and podcasts.

Remember to renew your TOPRA membership for 2026.

Already registered for free content?

If you are not a TOPRA member but have already created an account to access limited free content, log-in here using your registered user email and password.

Login

2. JOIN TOPRA

TOPRA membership

Become a TOPRA member and join our global regulatory affairs community.

  • Great savings on our events and training.
  • Be part of our dynamic international community.
  • Contribute to the profession.
  • Grow your skills and knowledge.
  • Take your career to the next level.
Become a member

3. REGISTER FOR FREE

Want free access to selected content?

Register now to continue to access industry news, editorials and podcasts plus one member-only journal article each month.

  • Create your own library to save your favourite content.
Create a free account